After settlement talks involving numerous medication distributors failed to yield an agreement on Oct. 18, Henry Schein is among the companies set to face a trial regarding the nation’s opioid epidemic.
The trial is slated to begin Monday, Oct. 21 in Cleveland federal court before U.S. District Court Judge Dan Polster.
While it’s still possible for an agreement to be reached before trial, issues regarding the distribution of funds and varying perspectives among the litigants prevented an agreement.
Towns, counties and states nationwide have sued numerous medication distributors, including the three largest, as well as Melville-based Henry Schein, which has denied any wrongdoing.
Executives from AmerisourceBergen, Cardinal Health and McKesson, the three biggest medication distributors, reportedly proposed an $18 billion settlement.
Executives from Israel-based generic drug maker Teva Pharmaceutical Industries reportedly attended the last minute talks.
Executives from Henry Schein, named in the suit, filed in Ohio, and Walgreens also reportedly attended the talks before trial.
